The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma

Clinical trial NCT01673802 · COMPLETED

Trial details

NCT number: NCT01673802
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2012-08-01
Primary completion: 2014-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.